The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Management of bone metastases in cancer: A review
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
Schiller, J. H., Harrington, D., Belani, C. P., Langer, C., Sandler, A., Krook, J., Zhu, J., & Johnson, D. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011954 · Cited by 4,955
COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER
Chiller, J. O. H. S., Arrington, D. A. H., Elani, C. H. P. B., Anger, C., Andler, A. L. S., Rook, J. A. K., Hu, J., & Ohnson, D. A. H. J. (2002) · Cited by 3,730
Roodman, G. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030831 · Cited by 2,755
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
Coleman, R. E. (2001) · Cancer Treatment Reviews · doi:10.1053/ctrv.2000.0210 · Cited by 1,920
Saad, F., Gleason, D. M., Murray, R., Tchekmedyian, S., Venner, P., Lacombe, L., Chin, J. L., Vinholes, J. J., Goas, J. A., & Chen, B. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1458 · Cited by 1,656
Skeletal complications of malignancy
Coleman, R. E. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1588::aid-cncr9>3.0.co;2-g · Cited by 1,502
Noda, K., Nishiwaki, Y., Kawahara, M., Negoro, S., Sugiura, T., Yokoyama, A., Fukuoka, M., Mori, K., Watanabe, K., Tamura, T., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa003034 · Cited by 1,371
MIRELS, H. (1989) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198912000-00027 · Cited by 1,214
Saad, F., Gleason, D. M., Murray, R., Tchekmedyian, S., Venner, P., Lacombe, L., Chin, J. L., Vinholes, J. J., Goas, J. A., & Zheng, M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh141 · Cited by 1,201
Luckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Dr. Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,176
The clinical course of bone metastases from breast cancer
Coleman, R., & Rubens, R. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.13 · Cited by 1,084
Hortobagyi, G. N., Theriault, R. L., Porter, L., Blayney, D., Lipton, A., Sinoff, C., Wheeler, H., Simeone, J. F., Seaman, J., Knight, R. D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612123352401 · Cited by 1,026
Yin, J. J., Selander, K., Chirgwin, J. M., Dallas, M., Grubbs, B. G., Wieser, R., Massagué, J., Mundy, G. R., & Guise, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3523 · Cited by 986
Hillner, B. E., Ingle, J. N., Chlebowski, R. T., Gralow, J., Yee, G. C., Janjan, N. A., Cauley, J. A., Blumenstein, B. A., Albain, K. S., Lipton, A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.017 · Cited by 970
Dunford, J. E., Thompson, K., Coxon, F. P., Luckman, S. P., Hahn, F. M., Poulter, C. D., Ebetino, F. H., & Rogers, M. J. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38786-5 · Cited by 900
Rosen, L. S., Gordon, D., Kaminski, M., Howell, A., Belch, A. R., Mackey, J. R., Apffelstaedt, J., Hussein, M., Coleman, R. E., Reitsma, D. J., et al. (2001) · PubMed · Cited by 896
Major, P., Lortholary, A., Hon, J., Abdi, E., Mills, G., Menssen, H. D., Yunus, F., Bell, R., Body, J., Quebe-Fehling, E., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.558 · Cited by 858
Guise, T. A., Yin, J. J., Taylor, S. D., Kumagai, Y., Dallas, M., Boyce, B. F., Yoneda, T., & Mundy, G. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118947 · Cited by 851
van Tinteren, H., Hoekstra, O. S., Smit, E. F., van den Bergh, J. H., Schreurs, A. J., Stallaert, R. A., van Velthoven, P. C., Comans, E. F., Diepenhorst, F. W., Verboom, P., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08352-6 · Cited by 851
Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment
Diel, I. J., Solomayer, E.-F., Costa, S. D., Gollan, C., Goerner, R., Wallwiener, D., Kaufmann, M., & Bastert, G. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808063390601 · Cited by 809
Rosen, L. S., Gordon, D., Tchekmedyian, S., Yanagihara, R., Hirsh, V., Krzakowski, M., Pawlicki, M., de Souza, P., Zheng, M., Urbanowitz, G., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.105 · Cited by 729
Steenland, E., Leer, J., van Houwelingen, H., Post, W. J., van den Hout, W. B., Kievit, J., de Haes, H., Martijn, H., Oei, B., Vonk, E., et al. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00110-3 · Cited by 677
Lipton, A., Theriault, R. L., Hortobagyi, G. N., Simeone, J., Knight, R. D., Mellars, K., Reitsma, D. J., Heffernan, M., & Seaman, J. J. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000301)88:5<1082::aid-cncr20>3.0.co;2-z · Cited by 665
Bone Imaging in Metastatic Breast Cancer
Hamaoka, T., Madewell, J. E., Podoloff, D. A., Hortobagyi, G. N., & Ueno, N. T. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.181 · Cited by 656
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.593 · Cited by 648
Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate
Nelson, J. B., Hedican, S. P., George, D. J., Reddi, A. H., Piantadosi, S., Eisenberger, M. A., & Simons, J. W. (1995) · Nature Medicine · doi:10.1038/nm0995-944 · Cited by 622
Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients
Fourney, D. R., Schomer, D. F., Nader, R., Chlan-Fourney, J., Suki, D., Ahrar, K., Rhines, L. D., & Gokaslan, Z. L. (2003) · Journal of Neurosurgery: Spine · doi:10.3171/spi.2003.98.1.0021 · Cited by 611
Goetz, M. P., Callstrom, M. R., Charboneau, J. W., Farrell, M. A., Maus, T. P., Welch, T. J., Wong, G. Y., Sloan, J. A., Novotny, P. J., Petersen, I. A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.097 · Cited by 608
Theriault, R. L., Lipton, A., Hortobagyi, G. N., Leff, R., Glück, S., Stewart, J. F., Costello, S., Kennedy, I., Simeone, J., Seaman, J. J., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.846 · Cited by 604
Brown, J. E., Cook, R. J., Major, P., Lipton, A., Saad, F., Smith, M., Lee, K.-A., Zheng, M., Hei, Y.-J., & Coleman, R. E. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji002 · Cited by 559
Paterson, A. H., Powles, T. J., Kanis, J. A., McCloskey, E., Hanson, J., & Ashley, S. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.1.59 · Cited by 557
Bone metastases: pathophysiology and management policy.
Nielsen, O. S., Munro, A. J., & Tannock, I. F. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.3.509 · Cited by 486
Guise, T. A., & Mundy, G. R. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0323 · Cited by 472
Zhang, J., Dai, J., Qi, Y., Lin, D.-L., Smith, P., Strayhorn, C., Mizokami, A., Fu, Z., Westman, J., & Keller, E. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11685 · Cited by 452
Powell, G. J., Southby, J., Danks, J. A., Stillwell, R. G., Hayman, J., Henderson, M. A., Bennett, R. C., & Martin, T. J. (1991) · PubMed · Cited by 445
Bisphosphonates induce apoptosis in human breast cancer cell lines
Senaratne, S. G., Pirianov, G., Mansi, J. L., Arnett, T. R., & Langrish, V (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1131 · Cited by 428
Body, J.-J., Diel, I. J., Lichinitser, M. R., Kreuser, E. D., Dornoff, W., Gorbunova, V. A., Budde, M., & Bergström, B. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg367 · Cited by 413
Choi, S. J., Cruz, J. C., Craig, F., Chung, H., Devlin, R. D., Roodman, G. D., & Alsina, M. (2000) · Blood · doi:10.1182/blood.v96.2.671 · Cited by 408
Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.
SHREVE, P. D., Grossman, H. B., Gross, M. D., & Wahl, R. L. (1996) · Radiology · doi:10.1148/radiology.199.3.8638000 · Cited by 395
Staging Non-Small Cell Lung Cancer with Whole-Body PET
Marom, E. M., McAdams, H. P., Erasmus, J. J., Goodman, P. C., Culhane, D. K., Coleman, R. E., Herndon, J. E., & Patz, E. F. (1999) · Radiology · doi:10.1148/radiology.212.3.r99se21803 · Cited by 384
Bisphosphonates: Clinical Experience
Coleman, R. E. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90004-14 · Cited by 384
American Society of Clinical Oncology Guideline on the Role of Bisphosphonates in Breast Cancer
Hillner, B. E., Ingle, J. N., Berenson, J. R., Janjan, N. A., Albain, K. S., Lipton, A., Yee, G., Biermann, J. S., Chlebowski, R. T., Pfister, D. G., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.6.1378 · Cited by 383
Randomized, Placebo-Controlled Trial of Clodronate in Patients With Primary Operable Breast Cancer
Powles, T., Paterson, S., Kanis, J. A., McCloskey, E., Ashley, S., Tidy, A., Rosenqvist, K., Smith, I., Ottestad, L., Legault, S., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.080 · Cited by 377
Bisphosphonates for breast cancer
Pavlakis, N., & Stockler, M. (2002) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003474 · Cited by 360
Jagdev, S. P., Coleman, R. E., Shipman, C. M., Rostami-H, A., & Croucher, P. I. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1727 · Cited by 346
Small, E. J., Smith, M. R., Seaman, J. J., Petrone, S., & Kowalski, M. O. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.147 · Cited by 341
Saarto, T., Blomqvist, C., Virkkunen, P., & Elomaa, I. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.10 · Cited by 341
Body, J. J., Diel, I. J., Lichinitzer, M., Lazarev, A., Pecherstorfer, M., Bell, R., Tripathy, D., & Bergstrom, B. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601663 · Cited by 336
Schirrmeister, H., Guhlmann, A., Elsner, K., Kotzerke, J., Glatting, G., Rentschler, M., Neumaier, B., Träger, H., Nüssle, K., & Reske, S. N. (1999) · PubMed · Cited by 329
Bury, T., Barreto, A., Daenen, F., Barthelemy, N., Ghaye, B., & Rigo, P. (1998) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050291 · Cited by 315
Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.
van der Pluijm, G., Vloedgraven, H., van Beek, E., van der Wee-Pals, L., Löwik, C., & Papapoulos, S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118841 · Cited by 305
Clinical course and prognostic factors following bone recurrence from breast cancer
Coleman, R., Smith, P., & Rubens, R. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.52 · Cited by 293
Lewington, V. J., McEwan, A. J., Ackery, D. M., Bayly, R. J., Keeling, D. H., Macleod, P. M., Porter, A. T., & Zivanovic, M. A. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90257-e · Cited by 279
Käkönen, S.-M., Selander, K. S., Chirgwin, J. M., Yin, J. J., Burns, S., Rankin, W. A., Grubbs, B. G., Dallas, M., Cui, Y., & Guise, T. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202561200 · Cited by 276
Pain and depression in patients with cancer
Spiegel, D., Sands, S., & Koopman, C. (1994) · Cancer · doi:10.1002/1097-0142(19941101)74:9<2570::aid-cncr2820740927>3.0.co;2-3 · Cited by 272
Conte, P. F., Latreille, J., Mauriac, L., Calabresi, F., Santos, R., Campos, D., Bonneterre, J., Francini, G., & Ford, J. M. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.9.2552 · Cited by 268
Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases
Bagan, J. V., Murillo, J., Jimenez, Y., Poveda, R., Milian, M. A., Sanchis, J. M., Silvestre, F. J., & Scully, C. (2005) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.2004.00269.x · Cited by 266
Hiraga, T., Williams, P. J., Mundy, G. R., & Yoneda, T. (2001) · PubMed · Cited by 256
Resche, I., Chatal, J.-F., Pecking, A., Ell, P., Duchesne, G., Rubens, R., Fogelman, I., Houston, S., Fauser, A., Fischer, M., et al. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00155-x · Cited by 254
Ernst, D. S., Tannock, I. F., Winquist, E. W., Venner, P. M., Reyno, L., Moore, M. J., Chi, K., Ding, K., Elliott, C., & Parulekar, W. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.042 · Cited by 247
Markers of bone turnover for the management of patients with bone metastases from prostate cancer
Garnero, P., Buchs, N., Zekri, J., Rizzoli, R., Coleman, R. E., & Delmas, P. D. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1012 · Cited by 238
Molecular mechanisms of action of bisphosphonates
Rogers, M. J., Frith, J. C., Luckman, S. P., Coxon, F. P., Benford, H. L., M̈onkk̈onen, J., Auriola, S., Chilton, K. M., & Russell, R. G. G. (1999) · Bone · doi:10.1016/s8756-3282(99)00070-8 · Cited by 237
Dearnaley, D. P. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg038 · Cited by 234
Molecular Mechanisms of Tumor-Bone Interactions in Osteolytic Metastases
Chirgwin, J. M., & Guise, T. A. (2000) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v10.i2.50 · Cited by 233
Role of endothelin-1 in osteoblastic bone metastases
Guise, T. A., Yin, J. J., & Mohammad, K. S. (2003) · Cancer · doi:10.1002/cncr.11129 · Cited by 228
Corey, E., Brown, L. G., Quinn, J. E., Poot, M., Roudier, M. P., Higano, C. S., & Vessella, R. L. (2003) · PubMed · Cited by 227
Sanders, J. L., Chattopadhyay, N., Kifor, O., Yamaguchi, T., Butters, R. R., & Brown, E. M. (2000) · Endocrinology · doi:10.1210/en.141.12.4357 · Cited by 215
Fulfaro, F., Casuccio, A., Ticozzi, C., & Ripamonti, C. (1998) · Pain · doi:10.1016/s0304-3959(98)00135-3 · Cited by 196
Balloon kyphoplasty for the treatment of pathological vertebral compressive fractures
Gaitanis, I. N., Hadjipavlou, A. G., Katonis, P. G., Tzermiadianos, M. N., Pasku, D. S., & Patwardhan, A. G. (2005) · European Spine Journal · doi:10.1007/s00586-004-0767-4 · Cited by 196
Lipton, A., Small, E., Saad, F., Gleason, D., Gordon, D., Smith, M., Rosen, L., Ortu Kowalski, M., Reitsma, D., & Seaman, J. (2002) · Cancer Investigation · doi:10.1081/cnv-120014886 · Cited by 175
Yi, B., Williams, P. J., Niewolna, M., Wang, Y., & Yoneda, T. (2002) · PubMed · Cited by 172
Comparative Tolerability of Drug Therapies for Hypercalcaemia of Malignancy
Zojer, N., Keck, A. V., & Pecherstorfer, M. (1999) · Drug Safety · doi:10.2165/00002018-199921050-00004 · Cited by 167
Carducci, M. A., Nelson, J. B., Kathy Bowling, M., Rogers, T., Eisenberger, M. A., Sinibaldi, V., Donehower, R., Leahy, T. L., Carr, R. A., Isaacson, J. D., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.028 · Cited by 159
Bisphosphonates in breast cancer
Coleman, R. E. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi162 · Cited by 158
Cheran, S. K., Herndon, J. E., & Patz, E. F. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2003.11.008 · Cited by 151
Guise, T. A. (1998) · Endocrine Reviews · doi:10.1210/er.19.1.18 · Cited by 146
Markers of bone resorption in patients treated with pamidronate
Lipton, A., Demers, L., Curley, E., Chinchilli, V. M., Gaydos, L. J., Hortobágyi, G. N., Theriault, R. L., Clemens, D., Costa, L., Seaman, J. J., et al. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00277-9 · Cited by 139
Biochemical markers of bone turnover in patients with metastatic bone disease
DEMERS, L. M., Costa, L., Chinchilli, V. M., Gaydos, L. J., Curley, E., & Lipton, A. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.10.1489 · Cited by 133
Oades, G. M., Senaratne, S. G., Clarke, I., Kirby, R. S., & Colston, K. W. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000070685.34760.5f · Cited by 132
Hillner, B. E., Ingle, J. N., Chlebowski, R. T., & Theriault, R. L. (2004) · Breast Diseases A Year Book Quarterly · Cited by 118
Vinholes, J., Coleman, R. E., & Eastell, R. (1996) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(96)90021-3 · Cited by 117
Hultborn, R., Gundersen, S., Rydén, S., Holmberg, E. C., Carstensen, J. M., Wallgren, U.-B., Killany, S., Andreassen, L., Carlsson, G. U., Fahl, N., et al. (1999) · PubMed · Cited by 115
Pharmacologic profile of zoledronic acid: A highly potent inhibitor of bone resorption
Green, J. R., & Rogers, M. J. (2002) · Drug Development Research · doi:10.1002/ddr.10071 · Cited by 100
Effect of oral clodronate on metastatic bone pain: a double-blind, placebo-controlled study.
Robertson, A. G., Reed, N. S., & Ralston, S. H. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.9.2427 · Cited by 99
Wellington, K., & Goa, K. L. (2003) · Drugs · doi:10.2165/00003495-200363040-00009 · Cited by 95
Gayed, I. W., Vu, T., Johnson, M., Macapinlac, H., & Podoloff, D. (2003) · Molecular Imaging and Biology · doi:10.1016/s1536-1632(03)00036-2 · Cited by 85
Systematic review of bisphosphonates for hypercalcaemia of malignancy
Saunders, Y., Ross, J. R., Broadley, K. E., Edmonds, P. M., & Patel, S. (2004) · Palliative Medicine · doi:10.1191/0269216304pm914ra · Cited by 73
The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain
Liepe, K., Runge, R., & Kotzerke, J. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0625-0 · Cited by 72
Mundy, G. R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10133-2 · Cited by 71
Bone metastases in breast cancer, prostate cancer and myeloma.
Paterson, A. H. (1987) · PubMed · Cited by 64
Profiling the safety and tolerability of bisphosphonates
Body, J., Diel, I., & Bell, R. H. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.07.030 · Cited by 34
Heidenreich, A., & Ohlmann, C. (2004) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.4.6.991 · Cited by 19
Cited by
Henry, D. H., Costa, L., Goldwasser, F., Hirsh, V., Hungria, V., Prausova, J., Scagliotti, G. V., Sleeboom, H., Spencer, A., Vadhan-Raj, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.3304 · Cited by 1,263
Self-citationMacedo, F., Ladeira, K., Pinho, F., Saraiva, N., Bonito, N., Pinto, L., & Gonçalves, F. (2017) · Oncology Reviews · doi:10.4081/oncol.2017.321 · Cited by 775
Scagliotti, G. V., Hirsh, V., Siena, S., Henry, D. H., Woll, P. J., Manegold, C., Solal-Celigny, P., Rodriguez, G., Krzakowski, M., Mehta, N. D., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31826aec2b · Cited by 335
Self-citationLiberman, B., Gianfelice, D., Inbar, Y., Beck, A., Rabin, T., Shabshin, N., Chander, G., Hengst, S., Pfeffer, R., Chechick, A., et al. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0011-2 · Cited by 296
High intensity focused ultrasound: The fundamentals, clinical applications and research trends
Elhelf, I. A. S., Albahar, H., Shah, U., Oto, A., Cressman, E., & Almekkawy, M. (2018) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2018.03.001 · Cited by 264
Metadata
- Authors
- Selvaggi, G., & Scagliotti, G. V.
- Venue
- Critical Reviews in Oncology/Hematology
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 56
- Issue
- 3
- Pages
- 365-378
- ISSN
- 1040-8428 (ISSN-L)
- OpenAlex
- W1970222099
- Cited by
- 266
- References
- 92
- FWCI
- 2.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.